Since its foundation three years ago, AgenoLab GmbH & Co. KG in Stuttgart has become a leading service provider in the area of life sciences and biotechnology. The company’s cell culture technology unit focuses on the preparation of cells that can largely eliminate the need for animal testing. In the area of regenerative medicine, AgenoLab GmbH concentrates on the growth of skin cells as transplants for patients suffering from burns and chronic wounds. The development of further cell therapeutics is another area of interest. The company has recently launched an innovative full-thickness skin transplant for healing wounds using the patient’s own cells. Within the framework of the Users’ Centre for Regenerative Medicine in the Neckar-Alb and Stuttgart health region (REGiNA), which is currently in the process of being established, AgenoLab is being supported by the German Federal Ministry of Education and Research (BMBF) with just short of Euro 1 million for two projects, one of which is the development of the above-mentioned full-thickness skin transplant.

Reutlingen’s Lord Mayor Barbara Bosch took up the reins on 5 February 2010 as the new chair of the Supervisory Board of BioRegio STERN Management GmbH. The role of deputy is being taken on by the previous chairman, Dr. Walter Rogg.